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A rare case of hypofibrinogenemia combined with elevated fibrino(geno) lysis at the time of expected menstruation was reported, and fundamentals of the mechanism of hemorrhage and hemostatic procedure were discussed.
It is well known that fibrinolysis in the circulating blood and in the endometrial tissue is elevated during a menstrual period. However, the occurrence of hypofibrinogenemia at the time of an expected normal menstruation has not been reported.
Here is described such a rare case found in a 35 year old woman. Present illness: She suddenly had a massive hemorrhage (about 500-700 ml.) from the uterus while walking on the street on March 23, 1963, this time correspond ing to the date of her normal expected menstrual period. It was painless. She was admitted to a hospital. The patient was treated with blood transfusion, ergot derivative, thromboplastic coagulants and vaginal tampon. However, the bleeding could not be adequately controlled during 5 days after the admission. She was, therefore, transferred to the University Hospital. Course and therapy: After taking blood samples for the laboratory examina tion, epsilon aminocaproic acid, a synthetic, highly active antiplasmic sub stance, was administered to the patient in doses of 3 g . orally every 6 hours for 7 days, and 2 g. intravenously twice a day for 4 days . Dicynone, a new hemo statica, having a chemical structure of diehylamine 4-cyclohexadiol 1-one 4-sulfonate (cyclonamine), and vitamin K1 were also given. Hormone therapy was not in dicated. One day after the therapy, the uterine bleeding gradually decreased but not completely. In order to examine the endometrium , curettage was performed uneventfully under Methergine injection on the second day of admission . Thick endometrial tissue could be curretted only from the region of the right cornua of the uterine cavity. Endometrial biopsy showed a nearly normal structure of the early proliferative phase, however, a slight degree of intrastromal hemorrhage was noted. As the laboratory determination of fibrinogen showed a lowered concentration, one gram of fibrinogen which might be considered too small an amount for complete correction of the lowered fibrinogen level , was transfused intravenously. From the third day of admission , uterine bleeding stopped almost completely. She was discharged after 9 days of hospitalization , and has rem ained well (Fig. 1) . COMMENT Acquired hypofibrinogenemia combined with pregnancy or surgical opera tion is not a rare occurrence. No report, however, could be found in the literature of hypofibrinogenemia during normal menstruation. In order to explain the causative factors and therapy of this patient, the general mechanism of hemor rhage will be discussed. When we encountered hemorrhage from any site, we should consider the causes and therapy of the hemorrhage from the aspect of three factors: 1. tissue factors (tissue elasticity, contractibility, thromboplastin and plasmin activity, etc.), 2. blood vessel factors (blood vessel size, elasticity, con tractibility, internal pressure, permeability, etc.), and 3. blood factors (all blood clotting factors including thrombocytes, anticlotting factors, plasmin system, etc.).
This consideration should be also applied for the understanding of the causative mechanism of uterine bleeding. When we find abnormal uterine bleeding in the non-pregnant woman, we should initially consider such organic changes as mechanical injuries, tumors, inflammations or hormonally induced endometrial disorders which may closely relate to the blood vessel and tissue factors. Subse quently, we may consider disorders of the clotting factors, thrombocytes and the possibility of plasmin activity in the endometrial tissue or in the circulating blood.
In this patient, the most impressive fact was the lowered fibrinogen concentra tion, 96.8 mg %, as compared with the normal value of 325 mg %.
As shown in the Table I , in this patient, the increase of fibrinolytic activity by the diluted plasma clot method, by the spontaneous fibrinolytic and fibrinogenolytic methods of the native euglobulin fraction, and by the thrombelastographic analysis were detected. On the other hand, normal spontaneous caseinolytic activity of the euglobulin fraction, decreased total plasmin and lowered antiplasmin were observed. At first sight, the normal caseinolytic activity and lowered total plasmin in this case seemed to be strange. However, the caseinolytic activity be comes, in general, less active when hemorrhage begins. The decrease of total plasmin, streptokinase-activatable proteolytic activity of euglobulin fraction, sug gests the consumption of plasminogen during the previous fibrino-(geno) lytic period. As to the cause of the antiplasmin decrease, two possible mechanisms can be enumerated. One is caused by consumption as a result of neutralizing the plasmin. And the other results from a disturbance of antiplasmin production. Which mechanism caused the decrease of antiplasmin was not certain in this case.
From the above reasons, one of the etiologic factors of this uterine bleeding seemed to be the enhancement of fibrino(geno)lysis in the circulating blood. An enhancement of fibrinolysis is also often found during normal menstruation, however, the occurrence of hypofibrinogenemia seemed to be very rare. Therefore, in this case, additional etiological factors should be considered to clarify the mechanism of the bleeding. The decrease of platelets found in this patient might play the role of enhancing the. bleedings. Platelets are, of course, an essential component of hemostasis. According to the reports of Hsu et al.') and Firkin et al.2) , and from our experience, a thrombocytopenic state was often found in cases of hypofibrinogenemia. However, it is not known whether this is a primary factor for the occurrence of this diseases or a secondary change of hypofibrinogen emia. Johnson and Schneider3) suggested that the platelets contain about 70% of the antiplasmin activity of the blood, so it may be thought that the fibrinolysin demonstrated in this patient was an expression of the low platelet count. However, an elevation of fibrinolysis was not always demonstrated in severe essential thrombocytopenic purpura. Ikami et al.4) reported that the plasmin destroyed the platelets. We have experienced another case of a woman who had massive hemorrhage from the uterus and nose, and generalized purpura with marked fibrinolysis and thrombocvtonenia.
Thus, the authors emphasize that on encountering abnormal bleeding from any site, one should consider the cause of hemorrhage and hemostasis from the above mentioned three factors.
